Literature DB >> 17302895

Immunological response to cytomegalovirus in congenitally infected neonates.

J Hassan1, S Dooley, W Hall.   

Abstract

Cytomegalovirus (CMV) is the most common cause of congenital infection worldwide and occurs as a result of transplacental transmission of the virus. The human neonate is highly susceptible to infection due to a combination of immaturity of the immune system and antigenic inexperience. This study uses the in vivo model of congenital CMV to examine both the humoral and cell-mediated immune responses in vertically infected neonates and their mothers. Ten pairs of matched neonates and their mothers were evaluated for specific IgM responses to three immunodominant CMV antigens: pp38 (pUL80a), pp52 (pUL44) and pp150 (pUL32). In contrast to conventional enzyme immunoassay (EIA) testing for CMV-specific IgM, which found five of the mothers and four of the neonates to be positive, Western immunoblotting showed all 10 adults and nine newborns to be positive. Eight mothers and nine newborns had serological evidence of primary infection. All neonates showed a response to pp38, an assembly protein, nine responded to the pp52 immediate early antigen but only four had reactivity to the pp150 tegument associated protein. Of the mothers, eight had pp38 reactivity, 10 showed a response to the pp52 antigen and seven to the pp150 antigen. T cell-mediated immunity was assessed by measuring cytokines using a multiplex microarray assay. Levels of interferon (IFN)-gamma were high in both groups [mean +/- standard error of the mean (s.e.m.): neonates = 657 +/- 238 pg/ml, mothers = 1072 +/- 677 pg/ml, pNS]; however, neonates had significantly higher levels of interleukin (IL)-8 (316 +/- 136 pg/ml versus 48 +/- 28 pg/ml, P < 0.005). Similar levels of IL-2, IL-7, IL-10 and IL-12 were measured in both groups, but levels of IL-1alpha, IL-1beta, IL-4, IL-6 and tumour necrosis factor (TNF)-alpha were either absent or low. In response to CMV, neonates and adults mount a predominant T helper 1 (Th1) response, as evidenced by the presence of IL-2, IL-8, IL-12 and IFN-gamma with concomitant lack of IL-4. These findings suggest that the neonate, when presented with infection in utero, is capable of mounting an individual response; however, the lower IFN-gamma and higher IL-8 levels suggest reduced immune responsiveness when compared to their adult counterparts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302895      PMCID: PMC1810494          DOI: 10.1111/j.1365-2249.2007.03302.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells.

Authors:  Gregory P White; Paul M Watt; Barbara J Holt; Patrick G Holt
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

Review 2.  Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.

Authors:  Robert F Pass; Rae Lyn Burke
Journal:  Semin Pediatr Infect Dis       Date:  2002-07

3.  IL-2 and IL-10 levels in induced sputum and serum samples of asthmatics.

Authors:  B Bagci Ceyhan; F Yilmaz Enc; S Sahin
Journal:  J Investig Allergol Clin Immunol       Date:  2004       Impact factor: 4.333

4.  Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis.

Authors:  I Nupponen; S Andersson; A L Järvenpää; H Kautiainen; H Repo
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

5.  Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology.

Authors:  Kristin Skogstrand; Poul Thorsen; Bent Nørgaard-Pedersen; Diana E Schendel; Line C Sørensen; David M Hougaard
Journal:  Clin Chem       Date:  2005-08-04       Impact factor: 8.327

6.  Serum cytokine responses during acute human granulocytic ehrlichiosis.

Authors:  J S Dumler; E R Trigiani; J S Bakken; M E Aguero-Rosenfeld; G P Wormser
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

7.  Cord blood levels of cytokines as predictors of early neonatal sepsis.

Authors:  C Santana; M C Guindeo; G González; F García-Muñoz; P Saavedra; E Doménech
Journal:  Acta Paediatr       Date:  2001-10       Impact factor: 2.299

8.  Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis.

Authors:  C Romagnoli; S Frezza; A Cingolani; A De Luca; M Puopolo; M P De Carolis; G Vento; A Antinori; G Tortorolo
Journal:  Eur J Pediatr       Date:  2001-06       Impact factor: 3.183

9.  Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells.

Authors:  Joseph E De Larco; Beverly R K Wuertz; Douglas Yee; Brenda L Rickert; Leo T Furcht
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

10.  Mature CD8(+) T lymphocyte response to viral infection during fetal life.

Authors:  Arnaud Marchant; Victor Appay; Marianne Van Der Sande; Nicolas Dulphy; Corinne Liesnard; Michael Kidd; Steve Kaye; Olubukola Ojuola; Geraldine M A Gillespie; Ana L Vargas Cuero; Vincenzo Cerundolo; Margaret Callan; Keith P W J McAdam; Sarah L Rowland-Jones; Catherine Donner; Andrew J McMichael; Hilton Whittle
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more
  13 in total

1.  Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen.

Authors:  Joanna M Schaenman; Sumana Shashidhar; Chanu Rhee; Jonathan Wong; Shelly Navato; Ruby M Wong; Dora Y Ho; Sally Arai; Laura Johnston; Janice M Brown
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-22       Impact factor: 5.742

Review 2.  Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.

Authors:  Marcus Altfeld; Madeleine J Bunders
Journal:  Semin Immunopathol       Date:  2016-07-08       Impact factor: 9.623

3.  Human cytomegalovirus UL144 is associated with viremia and infant development sequelae in congenital infection.

Authors:  Allison Waters; Jaythoon Hassan; Cillian De Gascun; Ghia Kissoon; Susan Knowles; Eleanor Molloy; Jeff Connell; William W Hall
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

Review 4.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

5.  Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants.

Authors:  Hayley A Gans; Linda L Yasukawa; Cathryn Z Zhang; Rima Hanna Wakim; Mary Rinki; Ross Dehovitz; Ann M Arvin
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

6.  The immune response to human CMV.

Authors:  Corinna La Rosa; Don J Diamond
Journal:  Future Virol       Date:  2012-03-01       Impact factor: 1.831

Review 7.  Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on.

Authors:  J Hassan; J Connell
Journal:  Clin Exp Immunol       Date:  2007-08       Impact factor: 4.330

8.  A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus.

Authors:  Yoshimi Tsuda; Patrizia Caposio; Christopher J Parkins; Sara Botto; Ilhem Messaoudi; Luka Cicin-Sain; Heinz Feldmann; Michael A Jarvis
Journal:  PLoS Negl Trop Dis       Date:  2011-08-09

Review 9.  Cytomegalovirus in the neonate: immune correlates of infection and protection.

Authors:  Mark R Schleiss
Journal:  Clin Dev Immunol       Date:  2013-08-19

Review 10.  Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.

Authors:  Gloria S Pryhuber
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.